EUROPEAN NON-INTERVENTIONAL POST-AUTHORIZATION SAFETY STUDY RELATED TO ADHERENCE TO THE RISK MINIMIZATION MEASURES FOR ROMOSOZUMAB BY THE EU-ADR ALLIANCE First published 24/09/2020 Last updated 17/06/2024 EU PAS number:EUPAS35956 Study Ongoing